Jiangsu Zhengji Pharmaceutical Co., Ltd. is a national high-tech enterprise focusing on the invention of innovative drug structures, research and application of new technologies, and research, development and manufacture of specialty generic drugs. The company currently has two R&D centers in Nanjing and Suzhou, two production bases in Huai'an and Suzhou, and one production base under construction in Rizhao, Shandong.
The company currently has more than 1,000 employees, including about 200 professional research and technical personnel, and more than 30 personnel with master's, doctoral degrees or above, including many overseas-educated and foreign employees. The main senior management team consists of professionals in medicine, pharmacy, chemistry and management.
The therapeutic areas of the drugs researched, developed and manufactured by the company focus on antivirals, antitumor drugs and geriatric drugs. The antiviral field includes Remdesivir, Favipiravir, Peramivir, Oseltamivir, Baloxavir, Sofosbuvir, Ledipasvir, Velpatasvir, Bictegravir, etc.; antitumor drugs include Eribulin, Alectinib, Palbociclib, etc.; geriatric and degenerative disease drugs include Clopidogrel, Citicoline Sodium, Rebamipide, Bazedoxifene, etc. The company conducts research on innovative drugs through joint development, independent development and other methods, and has obtained relevant structural invention patents and technology application patents.
The company's main business models include own brands, joint development and contract manufacturing, and it carries out global operations. At present, it has obtained dozens of Chinese GMP certificates, owns a number of products approved by China's NMPA, the U.S. FDA, the EU EMA and Japan's PMDA, and cooperates with a number of well-known enterprises in R&D and manufacturing. The enterprise has repeatedly passed audits and on-site inspections by domestic and foreign customers, and its products cover many countries and regions.
The company is a pharmaceutical enterprise driven by R&D, with efficient and standardized production, and participating in global operations. Through years of accumulated R&D investment, successful M&A management, and the building of a global marketing team, the company has entered a fast-growth channel.
With "integrity and helping the world" as its core values, "develop science and technology, improve human health!" as its mission, and upholding the business and management philosophy of "valuing quality, thinking of innovation, seeking progress, and acting in compliance with standards," the company strives to make Zhengji Pharmaceutical a recognized outstanding pharmaceutical enterprise in China and around the world.
Shuttle bus routes:
Jiangbei Line (first bus departs at 7:30): Tianruncheng Metro Station — Liuzhou East Road Metro Station — Daqiao — Aolin Plaza — Longhua Road Metro Station — Zifeng Innovation Center (Company)
Jiangnan Line (first bus departs at 7:30): Xinmofan Road Metro Station — Longjiang Metro Station — Jiqingmen Street Metro Station — Lanhuatang Metro Station — Zifeng Innovation Center (Company).
What does Nanjing Zhengji Pharmaceutical Research Co., Ltd. require? Who is Nanjing Zhengji Pharmaceutical Research Co., Ltd. hiring? recruitment: 经营管理类占比最多占37%,其次是生物/制药/化工/环保类占28.8%. What education can get in at ? 本科占比最多占65.8%,其次是硕士占17.8%. High education required at ? 硕士占17.8%. Work experience required at ? 5-10年占比最多占38.4%,其次是3-5年占26%. Where are the job locations at ? 苏州占比最多占57.5%,其次是日照占19.2%. Based on job postings from the past year, for reference only.
Congratulations, submitted successfully!
Your edit is under review. You will be notified by email within 1 business day.
Submission failed.
Help others learn about this company, add my impression of this company»
Log in with the following accounts to save your follows